Trevi Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Trevi Therapeutics, Inc. (TRVI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019
Current Assets
Cash and Cash Equivalents34.1082.97120.5136.8345.0057.31
Short-Term Investments73.5350.57107.920.000.000.00
Cash & Short-Term Investments107.6282.97120.5136.8345.0057.31
Accounts Receivable0.530.490.000.240.270.56
Inventory0.000.000.000.000.000.00
Other Current Assets0.870.961.310.891.000.00
Total Current Assets109.4387.55122.6237.9646.2759.55
Non-Current Assets
Property, Plant & Equipment (Net)1.231.560.190.180.330.43
Other Non-Current Assets0.240.300.210.330.530.00
Total Non-Current Assets1.471.860.400.520.860.45
Total Assets110.9089.40123.0238.4847.1360.00
Current Liabilities
Accounts Payable3.415.526.382.852.025.10
Short-Term Debt0.570.007.005.950.000.00
Current Portion of Long-Term Debt0.000.007.005.950.000.00
Accrued Liabilities4.272.103.523.813.430.00
Other Current Liabilities6.530.000.000.110.000.00
Total Current Liabilities10.515.8213.4012.725.565.20
Non-Current Liabilities
Long-Term Debt0.751.032.158.6513.950.26
Other Non-Current Liabilities0.000.000.000.000.200.00
Total Non-Current Liabilities0.751.032.168.6814.100.26
Total Liabilities11.266.8615.5621.4019.855.46
Stockholders' Equity
Common Stock0.090.070.060.030.020.00
Retained Earnings-287.05-239.16-210.19-180.92-146.98-114.22
Accumulated Other Comprehensive Income0.06-0.03-0.120.000.000.00
Additional Paid-in Capital386.53321.64317.59197.96174.24168.75
Shares Outstanding93.6068.2859.9428.510.000.00
Total Stockholders' Equity99.6482.55107.4617.0827.2854.55
Total Liabilities & Equity110.9089.40123.0238.4847.1360.00